Veracyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia.

CEO

Marc A. Stapley

CEOMarc A. Stapley

Employees

824

Employees824

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2006

Founded2006

Employees

824

Employees824

VCYT Key Statistics

Market cap

2.14B

Market cap2.14B

Price-Earnings ratio

83.20

Price-Earnings ratio83.20

Dividend yield

—

Dividend yield—

Average volume

3.14M

Average volume3.14M

High today

$28.69

High today$28.69

Low today

$27.35

Low today$27.35

Open price

$27.77

Open price$27.77

Volume

1.54M

Volume1.54M

52 Week high

$47.32

52 Week high$47.32

52 Week low

$22.61

52 Week low$22.61

VCYT News

Seeking Alpha 2d

Veracyte raises 2025 revenue guidance to $504M as Decipher volumes surge and strategic investments accelerate

Earnings Call Insights Veracyte raises 2025 revenue guidance to $504M as Decipher volumes surge and strategic investments accelerate Aug. 07, 2025 2:21 AM ET Ve...

Analyst ratings

82%

of 11 ratings

Buy

81.8%

Hold

9.1%

Sell

9.1%

People also own

Based on the portfolios of people who own VCYT. This list is generated using Robinhood data, and it’s not a recommendation.